Professional Summary
Professional Overview
Michael Har-Noy is a seasoned healthcare and biotechnology executive with over 15 years of experience as a founder, C-suite leader, and medical/scientific consultant. He has deep expertise in immunotherapy, oncology, and biopharmaceutical product development.
Experience Summary
Current Roles
As the Founder, Chief Medical Officer, Chief Operating Officer, and Director of Mirror Biologics, Inc., Michael is responsible for overseeing all aspects of the company's operations, product development, and strategic direction. He also serves as the Founder, Chairman, and CEO of Immunovative Therapies Ltd., and President/Chief Medical Officer of Immunovative Clinical Research, Inc. Additionally, Michael acts as a Medical and Scientific Consultant for Immunovative (Thailand) Co., Ltd. and the CEO/Director of Mirror Biologics, Ltd.
Career Progression
Michael's impressive career trajectory includes founding multiple biopharmaceutical companies and leading them in executive capacities. He has leveraged his deep scientific and medical expertise to drive innovation, clinical development, and commercialization of novel immunotherapies. Michael's ability to navigate complex regulatory environments and successfully advance product candidates through clinical trials has been instrumental in his professional success.
Academic Background
Michael holds a robust educational background, having received his medical degree. His specialized training and research focus have provided him with a strong foundation in immunology, oncology, and translational medicine.
Areas of Expertise
- Immunotherapy and oncology product development
- Biopharmaceutical operations and strategic planning
- Translational research and clinical trial design
- Regulatory affairs and market access
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Michael has made significant contributions to the advancement of immunotherapy and biopharmaceutical innovation. He has led the development of multiple investigational new drug candidates, some of which have demonstrated promising results in clinical trials. Michael's industry expertise and thought leadership have also been recognized through his participation in various scientific conferences and publications.
Conclusion
Michael Har-Noy's extensive experience as a successful founder, C-suite executive, and medical/scientific consultant positions him as a highly valuable asset in the healthcare and biotechnology industries. His proven track record of driving innovation, operational excellence, and clinical development makes him well-equipped to continue making a meaningful impact on patient outcomes and the advancement of novel therapies.
